As one of the world’s top players in life sciences, the UK boasts a strong biotech sector, which accounts for 30% of the total UK life sciences industry. While half of biotech companies are primarily involved in R&D services, more than a third are therapeutics and diagnostics companies, and the remaining 15% are other biotechs … Continue reading UK Life Science Trend Analysis 2023
Category: UK
Yearly Life Sciences Reports of the UK
United Kingdom Life Science Trend Analysis 2022
2021 was another record year for investments into UK life science companies.With a continued focus on tackling the COVID-19 pandemic, there was a remarkable increase in both the size and number of private financings compared to previous years. According to Biotechgate data for 2021, a record USD 3,138 million in venture capital was invested into … Continue reading United Kingdom Life Science Trend Analysis 2022
United Kingdom Life Science Trend Analysis 2021
2020 was a great year for the British biotech industry. The total value of private equity investments was twice as high compared to 2019 and exceeded the 2018 level that had been the highest since we begun tracking data. The UK remains the largest life science market in Europe when it comes to the number … Continue reading United Kingdom Life Science Trend Analysis 2021
UK Life Science Market Trend Analysis 2020
The number of financing rounds scored by UK private biotech companies in 2019 was the lowest since 2016. However, it still stays at a decent level and there is no sign of the British life science industry losing its position as the largest in Europe. Biotechgate lists more than 4,000 British companies that altogether have … Continue reading UK Life Science Market Trend Analysis 2020
UK Life Sciences Trend Analysis 2019
The United Kingdom is the largest European market when it comes to the number of life science companies. There are over 1,200 biotech companies based there with the total number of about 900 biopharmaceutical products being currently developed. 2018 was the record year in terms of the level of financing – 1,777 million USD was … Continue reading UK Life Sciences Trend Analysis 2019
UK Life Sciences Trend Analysis 2018
The UK market remains one of the strongest in Europe. The total value of venture investments in biotech and other life science companies was lower in 2017 than in two previous years, but the number of financing rounds was impressive.
UK Life Sciences Trend Analysis 2017
2016 was a quiet year for the UK Life Science Industry. After the relatively good first half of the year when more than twenty financing rounds were noted with over USD 500m invested, the second half saw a significant drop in financing activities. UK Life Science Trend Analysis 2017 Looking for your next Biotech … Continue reading UK Life Sciences Trend Analysis 2017
UK Life Sciences Trend Analysis 2015
2015 was a good year for Biotechnology Financing in the UK. Indeed the two semesters were stable at around 900m USD each. That is 10 times the amount of 2010 and over twice that of 2014. UK LS Trend Analysis 2015 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new … Continue reading UK Life Sciences Trend Analysis 2015
UK Life Sciences Trend Analysis 2014
2013 closed with the total venture financing value raised by Biotech companies in the U.K. being decreased by 47% compared to its 2012 level (USD 283m in 2013 compared to USD 530m in 2012). The number of U.K. biotech products (therapeutics and diagnostics) in the first stage of the clinical pipeline (Phase I) was increased … Continue reading UK Life Sciences Trend Analysis 2014
UK Life Sciences Trend Analysis 2013
From 2007 to 2012, the market witnessed a steady increase of biotech financing value in the UK. Moreover, the year 2012 almost doubled the financing value of 2011. Click here to download UK Life Sciences Trend Analysis 2013 – 12 pages